Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women, however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of death among them. Some of the most common types of breast cancer are ductal carcinoma in situ (DCIS), lobular carcinoma and invasive ductal carcinoma.

1. GLOBAL INDUSTRY INSIGHT:
Breast Cancer Market Size, Share, Development, Growth and Demand
Forecast to 2020

2. Global Breast Cancer Market Size, Share, Development, Growth
and Demand Forecast to 2020
Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer
and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women,
however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of
death among them. Some of the most common types of breast cancer are ductal carcinoma in situ (DCIS), lobular
carcinoma and invasive ductal carcinoma.
DCIS, also known as intraductal carcinoma, begins in the lining of the milk ducts. Milk ducts are thin tubes
carrying milk from lobules of the breast to the nipple. Lobule carcinoma originates in the lobules or milk glands of
the breast. Invasive ductal carcinoma is the most common type of breast cancer. It starts in a milk duct of the
breast, ruptures through the wall of the duct and grows into the fatty tissue of the breast. It spreads to other parts
of body through bloodstream.
For more information visit: https://www.psmarketresearch.com/market-analysis/-breast-cancer-market
The global breast cancer market covers various diagnostic technologies and therapeutic drugs. Diagnostic
segment is further sub-segmented into various tests which are used to diagnose breast cancer. Some of the
major diagnostic tests are biopsy, mammography, MRI, etc. Therapeutic segment covers hormone therapies and
chemotherapy drugs. Some of the major drugs are Trastuzumab, Bevacizumab, Anastrozole, Capecitabine,
Carboplatin, Denosumab, Docetaxel, Doxorubicin, Eribulin, Exemestane, Fluorouracil, Fulvestrant, Gemcitabine,
Ixabepilone, Lapatinib, Letrozole, Methotrexate, Paclitaxel and Tamoxifen.
North America accounts the largest global breast cancer market followed by Europe. The U.S., followed by
Canada, is the largest market for breast cancer in North America. Key driving factor for this market is increasing
prevalence of breast cancer in the region. Germany, France and the U.K. are some of the largest markets for
breast cancer in Europe region. However, Asia-Pacific represents the fastest growing region in the global breast
cancer market. This is due to improving healthcare infrastructure and increasing awareness among people about
breast cancer. In developing countries, such as China and India, government has launched several programs and
initiatives which increase awareness about the disease. It has led to significant rise in demand of breast cancer
diagnostics and therapeutics for disease management. In addition, less stringent wages and availability of skilled
labor attracts manufacturing companies to invest in developing countries.
Request for Table of Content: https://www.psmarketresearch.com/market-analysis/-Breast-Cancer-
Market/toc-sample
© P&S Market Research. All rights reserved 2

3. Global Breast Cancer Market Size, Share, Development, Growth
and Demand Forecast to 2020
Increasing prevalence of the disease is a key driving factor for the global breast cancer market. Increasing
awareness among people about the disease and rising number of geriatric women around the world are also
supporting the growth of global breast cancer market. In addition, increased research in the field of oncology and
development of biomarker has also fueled the growth of global breast cancer market. Increasing demand of
advanced therapeutic drugs and extensive drug pipeline holds immense potential to the growth of the global
breast cancer market.
However, patent expiry of various blockbuster drugs is key restraint of the global breast cancer market. Stringent
regulations and legislations and side-effects of chemotherapy drugs also hinder the growth of global breast
cancer market. Increasing mergers and acquisitions between drug manufacturing companies and government
bodies are some of the major trends in global breast cancer market.
Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/healthcare
Some of the major competitors in the market are Astrazeneca PLC, F. Hoffmann-La Roche Ltd, Eli Lilly and
Company, Novartis AG, Sanofi-Aventis. Pfizer, Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline
plc and Teva Pharmaceutical Industries Ltd.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports, industry forecasting reports,
business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate
forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through
their interaction with leading companies of the concerned domain. We help our clients with B2B market research
and assist them in identifying various windows of opportunity, and framing informed and customized business
expansion strategies in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
© P&S Market Research. All rights reserved 3

4. Global Breast Cancer Market Size, Share, Development, Growth
and Demand Forecast to 2020
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
© P&S Market Research. All rights reserved 4